Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.7K Sell
768
-110
-13% -$10K 0.03% 199
2026
Q1
$90.1K Buy
878
+82
+10% +$9.26K 0.04% 137
2025
Q4
$99.7K Buy
796
+28
+4% +$3.57K 0.04% 125
2025
Q3
$103K Hold
768
0.05% 110
2025
Q2
$104K Hold
768
0.06% 100
2025
Q1
$102K Hold
768
0.06% 96
2024
Q4
$86.9K Hold
768
0.06% 107
2024
Q3
$87.6K Hold
768
0.06% 116
2024
Q2
$79.8K Sell
768
-26
-3% -$2.76K 0.06% 112
2024
Q1
$90.2K Hold
794
0.07% 99
2023
Q4
$87.4K Buy
+794
New +$79.3K 0.07% 97

Other funds holding ABT

WealthCollab's ABT Position: Q2 2026 in Review

WealthCollab reduced its Abbott (ABT) stake by 13% in Q2 2026, selling an estimated $10K and leaving 768 shares worth $69.7K. The position accounts for 0.03% of the portfolio, ranked #199.

WealthCollab first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $104K in Q2 2025. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • WealthCollab held 768 shares of Abbott worth $69.7K as of Q2 2026.
  • WealthCollab sold 110 Abbott shares in Q2 2026, an estimated $10K.
  • Abbott made up 0.03% of WealthCollab's portfolio in Q2 2026, its #199 holding.
  • WealthCollab first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Abbott position peaked at $104K in Q2 2025.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.